genetics news from FierceBiotech
NewsCellCyte in 'precarious' shape after shares collapse
After a brief period as a high-flying stem cell company, CellCyte Genetics' share price Read more...
Study finds big gaps in clinical trial process
A new report out says that the clinical trial process routinely ignores women, the elderly, minorities, the disabled and people living in rural America. And the practice of ignoring large groups is Read more...
ALSO NOTED: Novartis licenses MedImmune vaccine IP; Rumor Mill: Dr. Reddy bids for Bradley; and much more...
> Rumor Mill: Generic drugmaker Dr. Reddy's Laboratories is said to have submitted a bid for U.S.-based Bradley Pharma. Read more...
Acceleron takes a lesson from the giant Belgian blue
The Boston Globe profiles the drug development work of Acceleron, which hopes to develop a therapy that regulates body tissues and systems. To help illustrate its efforts, researchers point Read more...
ALSO NOTED: Depomed surges on new data; FDA OKs Biomira study; and much more...> Shares of Depomed surged on the news that a Phase II trial has produced data that demonstrates significantly reduced pain scores for patients taking one of two doses of its Gabapentin GR painkiller. Report > Biomira and the FDA have agreed on a clinical trial design to test Stimuvax for advanced lung cancer. … Read more...Illumina to buy Solexa for $600MIllumina has agreed to buy Solexa, which makes genetics analysis systems, for $600 million. Illumina will also provide $50 million for Solexa, which specializes in whole genome sequencing. Illumina says it will maintain Solexa's operations in California and Cambridge, England. Solexa CEO John West becomes a senior vice president in the combined life science research firm. - here's the report on the buyout from MarketWatch C&L: Cell Genesys COO Vallner resigns
Cell Genesys announced that Joseph J. Vallner, Ph.D., the company's president and COO, has resigned to become the CFO of an early-stage, private biotechnology company. Le@p Technology has named Dr. Donald J. Ciappenelli as CEO and chairman. Access Genetics has named industry veteran … Read more...MedImmune gets nod for new vaccine techMedImmune announced that the FDA has approved its use of reverse genetics to make new vaccines. The new procedure significantly narrows the number of gene segments researchers study when creating a new vaccine, allowing a manufacturer like MedImmune to better target its research efforts and speed development. MedImmune has already used reverse genetics to develop an experimental vaccine for the H5N1 virus. It currently is in Phase I. - check out the … Read more...Reverse genetics used to create new vaccineUsing reverse genetics, a group of researchers at St. Jude's in Memphis has inactivated the avian flu virus and used it to successfully vaccinate ferrets. Researchers said that the vaccine also worked against two other strains, raising the prospect that the therapy could be used against mutated versions of avian flu. Reverse genetics also offers a new way to produce large amounts of vaccine in relatively short periods of time. No one knows when or if a pandemic may erupt, but avian flu … Read more...ALSO NOTED: BMS gets priority review for dastatinib; FDA votes to recommend Cubicin; and much more...> Bristol-Myers Squibb has gained priority review status for its oncology therapy dastatinib. Report > An FDA committee has voted to recommend Cubicin. Release > Biovail has restructured and announced that its chief scientific officer is stepping down. … Read more... | Press ReleasesPRESS RELEASE: Einstein Researchers Use Novel Approach to Uncover Genetic Components of Aging Einstein Researchers Use Novel Approach to Uncover Genetic Components of Aging August 24, 2007 –– People who live to 100 or more are known to have just as many—and sometimes Read more... Whitepapers and ReportsGenerics Series: Key Trends and Events in the 7 Major Markets Scope An overview of the generics industry across the 7 major markets. Coverage of regulatory and commercial developments within the generics industry. Analysis of the impact Read more... |
Get more genetics coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets